187 related articles for article (PubMed ID: 3891014)
1. Blood-brain barrier permeability to leucine-enkephalin, D-alanine2-D-leucine5-enkephalin and their N-terminal amino acid (tyrosine).
Zlokovic BV; Begley DJ; Chain-Eliash DG
Brain Res; 1985 Jun; 336(1):125-32. PubMed ID: 3891014
[TBL] [Abstract][Full Text] [Related]
2. Unidirectional uptake of enkephalins at the blood-tissue interface of the blood-cerebrospinal fluid barrier: a saturable mechanism.
Zlokovic BV; Segal MB; Davson H; Mitrovic DM
Regul Pept; 1988 Jan; 20(1):33-44. PubMed ID: 3127863
[TBL] [Abstract][Full Text] [Related]
3. Transport of leucine-enkephalin across the blood-brain barrier in the perfused guinea pig brain.
Zloković BV; Lipovac MN; Begley DJ; Davson H; Rakić L
J Neurochem; 1987 Jul; 49(1):310-5. PubMed ID: 3585338
[TBL] [Abstract][Full Text] [Related]
4. Co-localization of hypocretin-1 and leucine-enkephalin in hypothalamic neurons projecting to the nucleus of the solitary tract and their effect on arterial pressure.
Ciriello J; Caverson MM; McMurray JC; Bruckschwaiger EB
Neuroscience; 2013 Oct; 250():599-613. PubMed ID: 23912034
[TBL] [Abstract][Full Text] [Related]
5. Effects of various protease inhibitors on the stability and permeability of [D-Ala2,D-Leu5]enkephalin in the rat intestine: comparison with leucine enkephalin.
Uchiyama T; Kotani A; Kishida T; Tatsumi H; Okamoto A; Fujita T; Murakami M; Muranishi S; Yamamoto A
J Pharm Sci; 1998 Apr; 87(4):448-52. PubMed ID: 9548897
[TBL] [Abstract][Full Text] [Related]
6. Effects of amino acid chirality and the chemical linker on the cell permeation characteristics of cyclic prodrugs of opioid peptides.
Liederer BM; Fuchs T; Vander Velde D; Siahaan TJ; Borchardt RT
J Med Chem; 2006 Feb; 49(4):1261-70. PubMed ID: 16480263
[TBL] [Abstract][Full Text] [Related]
7. Kinetic analysis of leucine-enkephalin cellular uptake at the luminal side of the blood-brain barrier of an in situ perfused guinea-pig brain.
Zlokovic BV; Mackic JB; Djuricic B; Davson H
J Neurochem; 1989 Nov; 53(5):1333-40. PubMed ID: 2795003
[TBL] [Abstract][Full Text] [Related]
8. Effects of (D-Ala2,D-Leu5)enkephalinamide on isolated longitudinal muscle guinea pig and rat intestines.
Venkova K; Radomirov R; Petkov VD
Methods Find Exp Clin Pharmacol; 1987 May; 9(5):291-6. PubMed ID: 3613757
[TBL] [Abstract][Full Text] [Related]
9. Studies on the transport of enkephalin-like oligopeptides in rat intestinal mucosa.
Kerchner GA; Geary LE
J Pharmacol Exp Ther; 1983 Jul; 226(1):33-8. PubMed ID: 6345754
[TBL] [Abstract][Full Text] [Related]
10. Biochemical characterization of high-affinity 3H-opioid binding. Further evidence for Mu1 sites.
Nishimura SL; Recht LD; Pasternak GW
Mol Pharmacol; 1984 Jan; 25(1):29-37. PubMed ID: 6323950
[TBL] [Abstract][Full Text] [Related]
11. Opiate-like peptides. Part VIII. Methylamides and dimethylamides of [D-Leu5]-enkephalin and [D-Ala2, D-Leu5]-enkephalin. Synthesis and analgesic activity.
Rolka K; Kolasa K; Kleinrok Z; Kupryszewski G
Pol J Pharmacol Pharm; 1986; 38(4):391-402. PubMed ID: 3534824
[TBL] [Abstract][Full Text] [Related]
12. Stability of oxymethyl-modified coumarinic acid cyclic prodrugs of diastereomeric opioid peptides in biological media from various animal species including human.
Liederer BM; Borchardt RT
J Pharm Sci; 2005 Oct; 94(10):2198-206. PubMed ID: 16136552
[TBL] [Abstract][Full Text] [Related]
13. Characterization of hydrolysis of [leu]enkephalin and D-ala2-[L-leu]enkephalin in rat plasma.
Weinberger SB; Martinez JL
J Pharmacol Exp Ther; 1988 Oct; 247(1):129-35. PubMed ID: 2902210
[TBL] [Abstract][Full Text] [Related]
14. Cystamine-enkephalin dimer. Syntheses and biological activities of enkephalin analogs containing cystamine and cysteamine.
Kondo M; Kodama H; Costa T; Shimohigashi Y
Int J Pept Protein Res; 1986 Feb; 27(2):153-9. PubMed ID: 3009340
[TBL] [Abstract][Full Text] [Related]
15. Intrathecal administration of delta receptor agonists in the urethane anesthetized rat provokes an increase in arterial pressure via a non-opioid mechanism.
Rochford J; Henry JL
Brain Res; 1990 Apr; 512(2):259-68. PubMed ID: 2162234
[TBL] [Abstract][Full Text] [Related]
16. Characterization of D-Ala2,Leu5,Cys6-enkephalin: a novel synthetic opioid peptide with slowed dissociation from delta receptors.
Bowen WD; Kelemen M; Huey R; Stewart D
NIDA Res Monogr; 1986; 75():193-6. PubMed ID: 2828971
[TBL] [Abstract][Full Text] [Related]
17. [The effect of di- and trivalent metal ions on the binding of [3H-Tyr1, D-Ala2, D-Leu5] enkephalin to opiate receptors from the rat brain].
Porodenko NV; Zaĭtsev SV; Varfolomeev SD
Bioorg Khim; 1984 Jul; 10(7):902-11. PubMed ID: 6093821
[TBL] [Abstract][Full Text] [Related]
18. Lipophilic derivatives of leu-enkephalinamide: in vitro permeability, stability and in vivo nasal delivery.
Cros CD; Toth I; Blanchfield JT
Bioorg Med Chem; 2011 Feb; 19(4):1528-34. PubMed ID: 21273080
[TBL] [Abstract][Full Text] [Related]
19. [The nature of cation-binding groups in binding sites for [[3H]Tyr1, D-Ala2, D-Leu5]enkephalin].
Zaĭtsev SV; Porodenko NV; Varfolomeev SD
Bioorg Khim; 1985 Feb; 11(2):153-61. PubMed ID: 2986652
[TBL] [Abstract][Full Text] [Related]
20. A quantitative study of [3H]D-Ala2-D-Leu5-enkephalin binding to rat brain membranes. Evidence that oxymorphone is a noncompetitive inhibitor of the lower affinity delta-binding site.
Rothman RB; Bowen WD; Herkenham M; Jacobson AE; Rice KC; Pert CB
Mol Pharmacol; 1985 Mar; 27(3):399-409. PubMed ID: 2579319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
